Financials
- Market Capitalization 5.57 M
- Employee 3
- Founded 2010
- CEO N/A
- Website www.silopharma.com
- Headquarter Nevada, United States
- FIGI BBG002D1DZ06
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4944 | ADIL Adial Pharmaceuticals, Inc - Common Stock | 2.75 USD | -2.83% | -5.50% | -11.86% | +663.89% | 5.89 M USD | ||
| 4948 | PULM Pulmatrix, Inc. - Common Stock | 1.61 USD | -3.59% | -6.94% | +15.00% | -74.96% | 5.88 M USD | ||
| 4960 | APVO Aptevo Therapeutics Inc. - Common Stock | 4.46 USD | +7.47% | -0.89% | -6.69% | -33.93% | 5.56 M USD | ||
| 4962 | NCNA NuCana plc - American Depositary Shares | 1.33 USD | +3.91% | -5.67% | -33.83% | -38.14% | 5.54 M USD |
Frequently asked questions about Silo Pharma Inc -, effectuated 1:50 R/S on 9/15
What is the Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 stock price today?
The current price of Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 (SILO) is 5.14. Over the past 24 hours, the stock has changed by -2.65%. Follow the SILO chart for real-time price dynamics.
What is the stock ticker of Silo Pharma Inc -, effectuated 1:50 R/S on 9/15?
Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 trades under the ticker SILO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 stock going up?
SILO has changed by -16.01% over the last week, -21.04% over the last month, and +771.19% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 net income for the last quarter?
Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 reported net income of -1.65 M for the last quarter. The previous quarter showed -881.53 K, which means net income changed by -86.85%.
How many employees does Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 have?
As of the latest available data, Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 has 3 employees. Workforce size can provide additional context about the company's scale and operations.
What is Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 EBITDA?
Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 EBITDA is -1.59 M, and its EBITDA margin is -8 830.15%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 stock?
You can buy Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 (SILO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 stock?
Investing in Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SILO chart and related analysis on metatrader.com as part of your research.